Q&A With Robert Lisak from Wayne State University School of Medicine: New Research and Treatments Highlight CMSC Agenda

Video

It was a busy few days in Indianapolis for the Consortium of Multiple Sclerosis Centers. The annual meeting highlighted not only new treatments currently available to patients but also work coming down the pipeline for future options.

It was a busy few days in Indianapolis for the Consortium of Multiple Sclerosis Centers. The annual meeting highlighted not only new treatments currently available to patients but also work coming down the pipeline for future options.

Robert P. Lisak, MD, from the Wayne State University School of Medicine said advancements in the treatment of the relapsing form of the condition, and new research about the progressive form made for an informative session. Lisak, who also serves as President of the Consortium of Multiple Sclerosis Centers said he was also encouraged to see many new attendees at the event and the contributions made by first time people at the annual conference.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.